Zhejiang Wecome Pharmaceutical (SHE:300878) received an updated drug manufacturing license from the Zhejiang Provincial Medical Products Administration.
Under the update, Meng Zhaoguang has replaced Ding Jingwei as head of production, according to a Wednesday filing.
The company said the change was made for routine management purposes and will not have any material effect.